Q1 2018 13F Holders as of 31 Mar 2018
-
Type / Class
-
Equity / Common Stock, no par value
-
Shares outstanding
-
14,965,850
-
Total 13F shares
-
5,425,411
-
Share change
-
-5,311
-
Total reported value
-
$36,242,000
-
Price per share
-
$6.68
-
Number of holders
-
29
-
Value change
-
-$49,471
-
Number of buys
-
11
-
Number of sells
-
14
Institutional Holders of CUMBERLAND PHARMACEUTICALS INC - Common Stock, no par value (CPIX) as of Q1 2018
As of 31 Mar 2018,
CUMBERLAND PHARMACEUTICALS INC - Common Stock, no par value (CPIX) was held by
29 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
5,425,411 shares.
The largest 10 holders included
Stonepine Capital Management, LLC, ARIEL INVESTMENTS, LLC, DIMENSIONAL FUND ADVISORS LP, RENAISSANCE TECHNOLOGIES LLC, BlackRock Inc., VANGUARD GROUP INC, BRIDGEWAY CAPITAL MANAGEMENT INC, NEW YORK STATE COMMON RETIREMENT FUND, JW Asset Management, LLC, and ACADIAN ASSET MANAGEMENT LLC.
This page lists
29
institutional shareholders reporting positions in this security
for the Q1 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.